Selected research
Industry Research
Arbidol Tablets (COVID-19) Industry Research Report 2026
Market perspective
The global Arbidol Tablets (COVID-19) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Arbidol Tablets (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Arbidol Tablets (COVID-19) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Arbidol Tablets (COVID-19) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Arbidol Tablets (COVID-19) include Simcere Pharmaceutical, CSPC Ouyi Pharmaceutical, Jiangsu Wuzhong Pharmaceutical and JSC Pharmstandard, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Arbidol Tablets (COVID-19) market in terms of revenue (US$ million) and, where applicable, sales volume (M Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Arbidol Tablets (COVID-19) Market by Company
Simcere Pharmaceutical
CSPC Ouyi Pharmaceutical
Jiangsu Wuzhong Pharmaceutical
JSC Pharmstandard
Arbidol Tablets (COVID-19) Segment by Type
50mg
100mg
Arbidol Tablets (COVID-19) Segment by Application
Anti Influenza Virus
COVID-19
Arbidol Tablets (COVID-19) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arbidol Tablets (COVID-19) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Arbidol Tablets (COVID-19) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arbidol Tablets (COVID-19).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Arbidol Tablets (COVID-19) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Arbidol Tablets (COVID-19) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Arbidol Tablets (COVID-19) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50mg
- 100mg
Applications
- Anti Influenza Virus
- COVID-19
Companies covered
- Simcere Pharmaceutical
- CSPC Ouyi Pharmaceutical
- Jiangsu Wuzhong Pharmaceutical
- JSC Pharmstandard
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Arbidol Tablets (COVID-19) Market Size (2021-2032)
- 2.2.2 Global Arbidol Tablets (COVID-19) Sales (2021-2032)
- 2.2.3 Global Arbidol Tablets (COVID-19) Market Average Price (2021-2032)
- 2.3 Arbidol Tablets (COVID-19) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 50mg
- 2.3.3 100mg
- 2.4 Arbidol Tablets (COVID-19) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Anti Influenza Virus
- 2.4.3 COVID-19
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Arbidol Tablets (COVID-19) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Arbidol Tablets (COVID-19) Sales (M Pcs) of Manufacturers (2021-2026)
- 3.3 Global Arbidol Tablets (COVID-19) Revenue of Manufacturers (2021-2026)
- 3.4 Global Arbidol Tablets (COVID-19) Average Price by Manufacturers (2021-2026)
- 3.5 Global Arbidol Tablets (COVID-19) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Arbidol Tablets (COVID-19), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Arbidol Tablets (COVID-19), Product Type & Application
- 3.8 Global Manufacturers of Arbidol Tablets (COVID-19), Established Date
- 3.9 Global Arbidol Tablets (COVID-19) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Simcere Pharmaceutical
- 4.1.1 Simcere Pharmaceutical Company Information
- 4.1.2 Simcere Pharmaceutical Business Overview
- 4.1.3 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio
- 4.1.5 Simcere Pharmaceutical Recent Developments
- 4.2 CSPC Ouyi Pharmaceutical
- 4.2.1 CSPC Ouyi Pharmaceutical Company Information
- 4.2.2 CSPC Ouyi Pharmaceutical Business Overview
- 4.2.3 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio
- 4.2.5 CSPC Ouyi Pharmaceutical Recent Developments
- 4.3 Jiangsu Wuzhong Pharmaceutical
- 4.3.1 Jiangsu Wuzhong Pharmaceutical Company Information
- 4.3.2 Jiangsu Wuzhong Pharmaceutical Business Overview
- 4.3.3 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio
- 4.3.5 Jiangsu Wuzhong Pharmaceutical Recent Developments
- 4.4 JSC Pharmstandard
- 4.4.1 JSC Pharmstandard Company Information
- 4.4.2 JSC Pharmstandard Business Overview
- 4.4.3 JSC Pharmstandard Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 JSC Pharmstandard Arbidol Tablets (COVID-19) Product Portfolio
- 4.4.5 JSC Pharmstandard Recent Developments
5 Global Arbidol Tablets (COVID-19) Market Scenario by Region
- 5.1 Global Arbidol Tablets (COVID-19) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Arbidol Tablets (COVID-19) Sales by Region: 2021-2032
- 5.2.1 Global Arbidol Tablets (COVID-19) Sales by Region: 2021-2026
- 5.2.2 Global Arbidol Tablets (COVID-19) Sales by Region: 2027-2032
- 5.3 Global Arbidol Tablets (COVID-19) Revenue by Region: 2021-2032
- 5.3.1 Global Arbidol Tablets (COVID-19) Revenue by Region: 2021-2026
- 5.3.2 Global Arbidol Tablets (COVID-19) Revenue by Region: 2027-2032
- 5.4 North America Arbidol Tablets (COVID-19) Market Facts & Figures by Country
- 5.4.1 North America Arbidol Tablets (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Arbidol Tablets (COVID-19) Sales by Country (2021-2032)
- 5.4.3 North America Arbidol Tablets (COVID-19) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Arbidol Tablets (COVID-19) Market Facts & Figures by Country
- 5.5.1 Europe Arbidol Tablets (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Arbidol Tablets (COVID-19) Sales by Country (2021-2032)
- 5.5.3 Europe Arbidol Tablets (COVID-19) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Arbidol Tablets (COVID-19) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Arbidol Tablets (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Arbidol Tablets (COVID-19) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Arbidol Tablets (COVID-19) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Arbidol Tablets (COVID-19) Market Facts & Figures by Country
- 5.7.1 South America Arbidol Tablets (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Arbidol Tablets (COVID-19) Sales by Country (2021-2032)
- 5.7.3 South America Arbidol Tablets (COVID-19) Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Arbidol Tablets (COVID-19) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Arbidol Tablets (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Arbidol Tablets (COVID-19) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Arbidol Tablets (COVID-19) Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Arbidol Tablets (COVID-19) Sales by Type (2021-2032)
- 6.1.1 Global Arbidol Tablets (COVID-19) Sales by Type (2021-2032) & (M Pcs)
- 6.1.2 Global Arbidol Tablets (COVID-19) Sales Market Share by Type (2021-2032)
- 6.2 Global Arbidol Tablets (COVID-19) Revenue by Type (2021-2032)
- 6.2.1 Global Arbidol Tablets (COVID-19) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Arbidol Tablets (COVID-19) Revenue Market Share by Type (2021-2032)
- 6.3 Global Arbidol Tablets (COVID-19) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Arbidol Tablets (COVID-19) Sales by Application (2021-2032)
- 7.1.1 Global Arbidol Tablets (COVID-19) Sales by Application (2021-2032) & (M Pcs)
- 7.1.2 Global Arbidol Tablets (COVID-19) Sales Market Share by Application (2021-2032)
- 7.2 Global Arbidol Tablets (COVID-19) Revenue by Application (2021-2032)
- 7.2.1 Global Arbidol Tablets (COVID-19) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Arbidol Tablets (COVID-19) Revenue Market Share by Application (2021-2032)
- 7.3 Global Arbidol Tablets (COVID-19) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Arbidol Tablets (COVID-19) Value Chain Analysis
- 8.1.1 Arbidol Tablets (COVID-19) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Arbidol Tablets (COVID-19) Production Mode & Process
- 8.2 Arbidol Tablets (COVID-19) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Arbidol Tablets (COVID-19) Distributors
- 8.2.3 Arbidol Tablets (COVID-19) Customers
9 Global Arbidol Tablets (COVID-19) Analyzing Market Dynamics
- 9.1 Arbidol Tablets (COVID-19) Industry Trends
- 9.2 Arbidol Tablets (COVID-19) Industry Drivers
- 9.3 Arbidol Tablets (COVID-19) Industry Opportunities and Challenges
- 9.4 Arbidol Tablets (COVID-19) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst